GlassScriptPhysician profile
Brandy N Mountcastle
NPI 1043541659
$3,230.40
in general payments reported to CMS, 2019-2025
41 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $410 · 2022: $236 · 2023: $1,609 · 2024: $723 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,730 · Travel and Lodging: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,730.35 |
| Travel and Lodging | $854.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,067.09 | 2023 | Vns Therapy |
| Abbvie INC. | $435.89 | 2021-2025 | |
| Novo Nordisk INC | $271.71 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Valinor Pharma, LLC | $159.90 | 2023-2025 | Movantik |
| Amgen INC. | $135.26 | 2021-2024 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.06 | 2021-2024 | Jardiance |
| Scilex Pharmaceuticals INC. | $81.27 | 2022-2024 | Ztlido |
| Lilly USA, LLC | $78.08 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Otsuka America Pharmaceutical, INC. | $67.29 | 2024-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.39 | 2021-2023 | Relistor |
| Azurity Pharmaceuticals, INC. | $61.92 | 2023-2024 | Horizant, Horizant |
| Astrazeneca Pharmaceuticals LP | $58.43 | 2023-2024 | Farxiga, Breztri |
| Takeda Pharmaceuticals U.S.A., INC. | $53.52 | 2022-2024 | Trintellix |
| Pfizer INC. | $46.29 | 2021-2023 | |
| Axsome Therapeutics, INC. | $44.76 | 2023-2024 | Sunosi, Auvelity |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Mountcastle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.